Coherus Oncology, Inc. (CHRS) Executive Compensation
Coherus Oncology, Inc. (CHRS) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CHRS
CIK: 1512762
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerMarcus Lindner
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-08-28 | 2026-08-28 | 8-K | 0001104659-26-103316 | View SEC Doc Filr Page |
| 424B5 | 2026-08-28 | — | 424B5 | 0001104659-26-103241 | View SEC Doc Filr Page |
| 424B3 | 2026-08-28 | — | 424B3 | 0001104659-26-103239 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | 8-K | 0001104659-26-097951 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | 8-K | 0001104659-26-097949 | View SEC Doc Filr Page |
| S-8 | 2026-08-05 | — | S-8 | 0001104659-26-091276 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001104659-26-091262 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001104659-26-091188 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002236 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-12 | 8-K | 0001104659-26-074090 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000206 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000205 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000204 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000203 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000202 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000201 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-05 | 4 Filing | 0001610717-26-000200 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | OWNERSHIP DOCUMENT | 0001104659-26-069622 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | OWNERSHIP DOCUMENT | 0001104659-26-069621 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-27 | 8-K | 0001104659-26-068615 | View SEC Doc Filr Page |
| DEFA14A | 2026-05-28 | — | DEFA14A | 0001104659-26-067154 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0002109159-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001104659-26-058703 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001104659-26-058666 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0002109159-26-000002 | View SEC Doc Filr Page |